National Cancer Institute; Amended Notice of Meeting, 68678 [2021-26273]
Download as PDF
<![CDATA[
68678
Federal Register / Vol. 86, No. 230 / Friday, December 3, 2021 / Notices
Authority: 42 U.S.C. 200u.
Paul Reed,
Deputy Assistant Secretary for Health,RADM,
U.S. Public Health Service, Office of Disease
Prevention and Health Promotion.
[FR Doc. 2021–26184 Filed 12–2–21; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; HostBacterial Interactions and Infections.
Date: December 14, 2021.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pauline Cupit, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–3275, cupitcunninghpm@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 29, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–26247 Filed 12–2–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:06 Dec 02, 2021
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Advisory Board and NCI Board of
Scientific Advisors, December 7, 2021,
1:00 p.m. to December 9, 2021, 5:00
p.m., National Cancer Institute-Shady
Grove, 9609 Medical Center Drive,
Rockville, MD 20850 which was
published in the Federal Register on
October 05, 2021, FR Doc 2021–21666,
86 FR 54990.
This notice is being amended to
change the open session end time and
agenda on December 7, 2021. There will
now only be one NCAB Subcommittee
Meeting held on December 7, 2021, the
Ad Hoc Subcommittee on Experimental
Therapeutics from 1:15 p.m. to 2:15
p.m.
This notice is also being amended to
change the open session end times on
December 8, 2021 and December 9,
2021. The open session end time on
December 8, 2021 has changed from
5:00 p.m. to 5:30 p.m., as such, the
meeting will now be held from 1:00
p.m. to 5:30 p.m. The open session end
time on December 9, 2021 has changed
from 5:00 p.m. to 5:15 p.m., as such, the
meeting will now be held from 1:00
p.m. to 5:15 p.m. The meeting is
partially closed to the public.
Dated: November 30, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–26273 Filed 12–2–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cell, Molecular Biology and
Special Topics.
Date: December 15, 2021.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ronit I. Yarden, Ph.D.,
MHSA, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 904B,
Bethesda, MD 20892, (202) 552–9939,
yardenri@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 29, 2021.
David W. Freeman, Program Analyst,
Office of Federal Advisory Committee Policy.
[FR Doc. 2021–26250 Filed 12–2–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; AI/ML
strategies to integrate genetics and multiomics data from human cohort studies to
improve quality of life of Older Adults with
MCI and ADRD.
Date: January 19, 2022.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\03DEN1.SGM
03DEN1
]]>Agencies
[Federal Register Volume 86, Number 230 (Friday, December 3, 2021)]
[Notices]
[Page 68678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26273]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Advisory Board and NCI Board of Scientific Advisors, December 7,
2021, 1:00 p.m. to December 9, 2021, 5:00 p.m., National Cancer
Institute-Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850
which was published in the Federal Register on October 05, 2021, FR Doc
2021-21666, 86 FR 54990.
This notice is being amended to change the open session end time
and agenda on December 7, 2021. There will now only be one NCAB
Subcommittee Meeting held on December 7, 2021, the Ad Hoc Subcommittee
on Experimental Therapeutics from 1:15 p.m. to 2:15 p.m.
This notice is also being amended to change the open session end
times on December 8, 2021 and December 9, 2021. The open session end
time on December 8, 2021 has changed from 5:00 p.m. to 5:30 p.m., as
such, the meeting will now be held from 1:00 p.m. to 5:30 p.m. The open
session end time on December 9, 2021 has changed from 5:00 p.m. to 5:15
p.m., as such, the meeting will now be held from 1:00 p.m. to 5:15 p.m.
The meeting is partially closed to the public.
Dated: November 30, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-26273 Filed 12-2-21; 8:45 am]
BILLING CODE 4140-01-P
